Author

Xuejia Qiu

Observed name: Xue-Jia Qiu

Institution: Hebei General Hospital

Observed institutions: China Pharmaceutical University, Hebei General Hospital

ORCID: 0000-0002-3198-5370

Observed ORCID: 0000-0002-3198-5370

OpenAlex ID: A5078793262

The effects of sodium glucose co-transporter (SGLT) 2 inhibitors on hematocrit levels: a systematic review and meta-analysis of randomized controlled trials

2021 · Xiaonan Wang, Ran Fu, et al. · Annals of Palliative Medicine · 24

Therapeutic effect of astragaloside-IV on bradycardia is involved in up-regulating klotho expression

2015 · Xuejia Qiu, Qiao Guo, et al. · Life Sciences · 19

Acute liver injury induced by drug interaction between dacomitinib and metoprolol due to the inhibition of CYP2D6 by dacomitinib

2022 · Xuejia Qiu, Bingnan Ren, et al. · Journal of Oncology Pharmacy Practice · 8

Anti‑PD1 therapy‑associated distal renal tubular acidosis: A case report

2023 · Xuejia Qiu, Bingnan Ren, et al. · Experimental and Therapeutic Medicine · 6

[Meta-analysis of efficacy and safety of Tripterygium Glycosides Tablets combined with desloratadine in treatment of chronic urticarial].

2019 · Yan-Shuo Shi, Qi-Min Wang, et al. · PubMed · 4

Efficacy and safety of anlotinib combined with immune checkpoint inhibitors and platinum-containing chemotherapy for later-line advanced non-small cell lung cancer: a retrospective three-arm real-world study using propensity-score matching

2024 · Zeyang Wang, Bingnan Ren, et al. · Frontiers in Oncology · 1

Meta-analysis of the Effects of Shenqi Fuzheng Injection Combined with Conventional Chemotherapy on the Immune Function of Patients with Advanced NSCLC

2019 · Huizhen Wu, Xuejia Qiu, et al. · Zhongguo yaofang · 1

Hemolytic-uremic syndrome due to gemcitabine

2019 · Xuejia Qiu, Difei Yao, et al. · 药物不良反应杂志

抗pd-1/pd-l1の抗腫瘍免疫療法への応用【jst・京大機械翻訳】

2016 · Xuejia Qiu, Liu Yong, et al. · Zhongguo xin yao zazhi

Works count: 9

Citation count: 63

H-index: 4

I10-index: 2